【ABC-KY】February 2026 Revenue: NT$72 Million (YoY +81.3%)
Applied BioCode (ABC-KY) announced its February 2026 revenue was NT$72 million, a significant year-o… · 2026-02-01
ABC-KY News Releases
【ABC-KY】Monthly Revenue for May 2026: NT$0.60 Billion (YoY +134.9%)
ABC-KY announced its revenue for May 2026 at NT$603.07 million, representing a year-on-year increase… · 2026-05-01
[ABC-KY] Announcement of Important Resolutions from the 115th Annual General Meeting of Shareholders
ABC-KY approved the proposal for covering losses for fiscal year 2025 and the business report and co… · 2026-06-11
ABC-KY: March 2026 Revenue Reaches 66 Million Yen (Up 72.5% Year-on-Year)
ABC-KY reported its March 2026 revenue at 66.022 million yen (0.066 billion yen), marking a signific… · 2026-03-01
[ABC-KY] Clarification of Media Reports
Applied BioCode Corp. (ABC-KY) clarified a media report by 'Business Today' regarding its projected … · 2026-05-14
【ABC-KY】April 2026 Revenue: 60.98 Million Yen (Year-on-Year Increase of +41.8%)
ABC-KY reported strong April 2026 revenue of 60.98 million yen, showing a significant year-over-year… · 2026-04-01
【ABC-KY】Announcement of the Board of Directors' approval of the Q1 2026 consolidated financial report
ABC-KY's Board of Directors approved the consolidated financial report for the first quarter of 2026… · 2026-05-08
【ABC-KY】Announcement by Subsidiary Applied BioCode, Inc. that its 20-item Respiratory Pathogen Panel (RPP) and Automated Diagnostic System (MDx3000), combined with Thermo Fisher Scientific's KingFisher extraction instrument pre-processing system, have obtained US FDA market clearance.
ABC-KY's subsidiary, Applied BioCode, Inc., announced that its 20-item Respiratory Pathogen Panel (R… · 2026-05-02
ABC-KY Invited to Participate in Earnings Call Hosted by Taishin Securities
ABC-KY announced its participation in an earnings call organized by Taishin Securities on May 14, 20… · 2026-05-14
ABC-KY Announces Board Meeting Date for Q1 2026 Financial Report
ABC-KY announced that its board meeting to review the Q1 2026 financial report will be held on May 8… · 2026-04-30
ABC-KY Announces Board Meeting Date for Q1 2026 Financial Report
ABC-KY announced that its board meeting to review the Q1 2026 financial report will be held on May 8… · 2026-04-30
ABC-KY: March 2026 Revenue Reaches 66 Million Yen (Up 72.5% Year-on-Year)
ABC-KY reported its March 2026 revenue at 66.022 million yen (0.066 billion yen), marking a signific… · 2026-03-01
【ABC-KY】February 2026 Revenue: NT$72 Million (YoY +81.3%)
Applied BioCode (ABC-KY) announced its February 2026 revenue was NT$72 million, a significant year-o… · 2026-02-01
[ABC-KY] Clarification of Media Reports
Applied BioCode Corp. (ABC-KY) clarified a media report by 'Business Today' regarding its projected … · 2026-05-14
【ABC-KY】April 2026 Revenue: 60.98 Million Yen (Year-on-Year Increase of +41.8%)
ABC-KY reported strong April 2026 revenue of 60.98 million yen, showing a significant year-over-year… · 2026-04-01
ABC-KY Invited to Participate in Earnings Call Hosted by Taishin Securities
ABC-KY announced its participation in an earnings call organized by Taishin Securities on May 14, 20… · 2026-05-14
ABC-KY Announces Board Meeting Date for Q1 2026 Financial Report
ABC-KY announced that its board meeting to review the Q1 2026 financial report will be held on May 8… · 2026-04-30
【ABC-KY】Announcement by Subsidiary Applied BioCode, Inc. that its 20-item Respiratory Pathogen Panel (RPP) and Automated Diagnostic System (MDx3000), combined with Thermo Fisher Scientific's KingFisher extraction instrument pre-processing system, have obtained US FDA market clearance.
ABC-KY's subsidiary, Applied BioCode, Inc., announced that its 20-item Respiratory Pathogen Panel (R… · 2026-05-02
【ABC-KY】Announcement of the Board of Directors' Approval of the Q1 2026 Consolidated Financial Report
ABC-KY announced the approval of its consolidated financial statements for the first quarter of 2026… · 2026-05-08